Valiant Organics · NSE: VALIANTORG · BSE: 540145

Q2 FY25 results · Jul–Sep 2024

Valiant Organics reported revenue from operations of ₹160.18 crore (down 21.1% from Q2 FY24) and net loss of ₹12.47 crore for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.

Consolidated · ₹ crore
Item	Q2 FY25	Q2 FY24	YoY	Q1 FY25	QoQ
Revenue from operations	160.18	203.10	−21.1%	167.92	−4.6%
Other income	2.53	3.63	−30.3%	0.38	+563.6%
Total income	162.71	206.73	−21.3%	168.30	−3.3%
Profit before share of associates & JVs and tax	(12.14)	6.41	Turned loss	2.40	Turned loss
Share of profit/(loss) of associates & JVs	(1.62)	0.00		(0.17)
Net profit for the period	(12.47)	4.75	Turned loss	(0.62)	Loss widened
Attributable to shareholders of the company	(12.78)	4.30	Turned loss	(0.62)	Loss widened
EPS, basic (₹)	(4.52)	1.58	Turned loss	(0.23)	Loss widened
Net margin (%)	-7.8	2.3		-0.4

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q2 FY25	Q2 FY24	YoY	Q1 FY25	QoQ
Revenue from operations	160.18	182.48	−12.2%	167.92	−4.6%
Other income	2.02	0.23	+796.3%	0.38	+429.4%
Total income	162.20	182.70	−11.2%	168.30	−3.6%
Profit before tax	(12.65)	5.31	Turned loss	2.41	Turned loss
Net profit for the period	(11.16)	3.92	Turned loss	(0.44)	Loss widened
EPS, basic (₹)	(4.37)	1.44	Turned loss	(0.16)	Loss widened
Net margin (%)	-7.0	2.1		-0.3

Consolidated

Filed with BSE: 13 Nov 2024, 22:28 IST
Board meeting: 13 Nov 2024
Period: 01 Jul 2024 to 30 Sep 2024
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 13 Nov 2024, 22:28 IST
Board meeting: 13 Nov 2024
Period: 01 Jul 2024 to 30 Sep 2024
Review status: Unaudited
Source: XBRL filing on BSE